FB2024_04 , released June 25, 2024
Human Disease Model Report: centronuclear myopathy 1
Open Close
General Information
Name
centronuclear myopathy 1
FlyBase ID
FBhh0000093
Disease Ontology Term
Parent Disease
Overview

This report describes centronuclear myopathy 1 (CNM1), which is a subtype of centronuclear myopathy; CNM1 exhibits autosomal dominant inheritance. The human gene implicated in this disease is Dynamin 2, DNM2, which encodes a large force-producing GTPase associated with microtubules and involved in endocytosis and intracellular membrane trafficking. DNM2 is implicated in multiple other diseases, including forms of Charcot-Marie-Tooth disease (see MIM:602378). There is a single fly ortholog, Dmel\shi, for which classical loss-of-function alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated. Dmel\shi is also the highest scoring ortholog for two additional human dynamins, DNM1 and DNM3.

Multiple different UAS constructs of the human Hsap\DNM2 gene have been introduced into flies, including wild-type DNM2 and genes carrying mutational lesions implicated in CNM1. Animals carrying mutant alleles of Hsap\DNM2 exhibit reduced viability, locomotor behavior defective phenotypes, muscle fiber atrophy, and exhibit cellular abnormalities in larval muscles.

Variant(s) implicated in human disease tested (as transgenic human gene, DNM2): the variant forms R465W, A618T, and S619L of the human gene have been introduced into flies. A variant implicated in Charcot-Marie-Tooth disease (FBhh0000973) has also been tested in flies.

Loss-of-function mutations in the Dmel\shi gene are lethal; multiple temperature-sensitive alleles have been isolated. A UAS-heat-sensitive allele produces neuroanatomy defective, behavior defective, paralytic, chemical resistant and other phenotypes, depending upon the GAL4 driver used. Genetic and physical interactions of Dmel\shi have been described; see below and in the shi gene report.

[updated Feb. 2019 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: centronuclear myopathy
Symptoms and phenotype

Centronuclear myopathy is a congenital myopathy characterized by slowly progressive muscular weakness and wasting; the disorder involves mainly limb girdle, trunk, and neck muscles but may also affect distal muscles; ptosis (drooping eyelid) and limitation of eye movements may occur. Age of onset varies, from childhood to young adulthood. (Bitoun et al., 2005, pubmed:16227997). [from MIM:160150; 2015.12.16]

Specific Disease Summary: centronuclear myopathy 1
OMIM report

[MYOPATHY, CENTRONUCLEAR, 1; CNM1](https://omim.org/entry/160150)

Human gene(s) implicated

[MYOTUBULARIN-RELATED PROTEIN 14; MTMR14](https://omim.org/entry/611089)

[DYNAMIN 2; DNM2](https://omim.org/entry/602378)

Symptoms and phenotype

See general description of symptoms of centronuclear myopathy, above.

Genetics

A map of mutations of DNM2 implicated in CNM1 and in Charcot-Marie-Tooth (CMT) disease is shown in Bohm et al., 2012 (pubmed:22396310). Mutations of CMT most frequently affect the PH domain, with one example in the MID region; there is no overlap between the two diseases in terms of nucleotides affected.

Centronuclear myopathy 1 (CNM1) is inherited as an autosomal dominant and is usually caused by heterozygous mutation in the gene encoding Dynamin-2 (DNM2). Age of onset ranges from childhood to early adulthood.[from MIM:160150; 2015.12.17]

Cellular phenotype and pathology
Molecular information

Dynamin 2 is a microtubule-associated force-producing protein involved in producing microtubule bundles and able to bind and hydrolyze GTP. Plays a role in the regulation of neuron morphology, axon growth and formation of neuronal growth cones (by similarity); in vesicular trafficking processes, in particular endocytosis; and in cytokinesis.

[Gene Cards, DNM2; 2019.02.20]

DNM2 is a ubiquitously expressed large GTPase involved in clathrin-dependent and-independent endocytosis and intracellular membrane trafficking. DNM2 interacts tightly with actin and microtubule networks and may have a role in centrosome function (summary by Durieux et al., 2010; pubmed:20858595). [from MIM:602378; 2015.12.17] The most common mutations in CNM1 are in the middle (MID) domain (required for tetramer formation), followed by the pleckstrin homology (PH) domain and the PH-GED linker; mutations in the GTPase effector (GED) domain are rare (Bohm et al., 2012; pubmed:22396310). [from MIM:160150; 2015.12.17]

External links
Disease synonyms
ADCNM
autosomal dominant centronuclear myopathy-1
CNM1
myopathy, centronuclear
myopathy, centronuclear 1
myotubular myopathy
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
Symbol / Name
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to one: 3 human to 1 Drosophila; additional orthologous human genes are DNM1 and DNM3.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Groups / Pathways
    Comments on ortholog(s)

    Ortholog of human DNM1, DNM2, and DNM3 (1 Drosphila to 3 human). Dmel\shi shares 66% identity and 78% similarity with each of the 3 human genes.

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (14 groups)
      protein-protein
      Interacting group
      Assay
      References
      anti bait coimmunoprecipitation, western blot
      anti tag coimmunoprecipitation, anti tag western blot
      pull down, western blot, far western blotting, molecular weight estimation by staining, edman degradation, anti bait coimmunoprecipitation, autoradiography, cosedimentation
      pull down, autoradiography, anti tag coimmunoprecipitation, peptide massfingerprinting
      pull down, western blot, anti bait coimmunoprecipitation
      anti bait coimmunoprecipitation, western blot
      anti tag coimmunoprecipitation, peptide massfingerprinting
      pull down, western blot, two hybrid, anti bait coimmunoprecipitation
      anti tag coimmunoprecipitation, peptide massfingerprinting
      anti tag coimmunoprecipitation, peptide massfingerprinting
      pull down, western blot, Identification by mass spectrometry
      cosedimentation, western blot
      pull down, western blot
      cosedimentation, western blot
      Alleles Reported to Model Human Disease (Disease Ontology) (10 alleles)
      Models Based on Experimental Evidence ( 2 )
      Allele
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 6 )
      Models Based on Experimental Evidence ( 3 )
      Modifiers Based on Experimental Evidence ( 0 )
      Allele
      Disease
      Interaction
      References
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      ethyl methanesulfonate
      loss of function allele
      X ray
      loss of function allele
      ethyl methanesulfonate
      ethyl methanesulfonate
      loss of function allele
      ethyl methanesulfonate
      References (8)